We have recently demonstrated that the presence or absence of IGFBP-3 prote
ase activity in physiological fluids may not be determined simply by the pr
esence or absence of specific enzymes but rather the presence of inhibitors
. In addition, it appears that these inhibitors may not only be associated
with the protease(s) but with the IGFBP-3 itself, protecting it from proteo
lytic cleavage. To provide further evidence for this mechanism of regulatio
n we investigated whether IGFBP-3 protease activity could be unveiled in no
rmal adult serum (NS) and whether the endogenous IGFBP-3 was protected from
this activity. The addition of a range of concentrations of heparin, induc
ed IGFBP-3 protease activity in NS. This was comparable to that seen in pre
gnancy serum (PS) by virtue of the fragmentation pattern and inhibitor prof
ile. While the addition of zinc also revealed IGFBP-3 protease activity in
NS the pattern of fragments differed to that seen in PS. Under both conditi
ons, however, the endogenous IGFBP-3 was not proteolytically modified. Thes
e results demonstrate that IGFBP-3 protease activity is present in NS and c
an be activated, although the endogenous IGFBP-3 is relatively protected fr
om such activity. (C) 2000 Harcourt Publishers Ltd.